Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.

Objective And Background: Budesonide/formoterol 160/4.5 microg, two inhalations bd, is an effective and well-tolerated maintenance therapy for patients not controlled on inhaled corticosteroids alone. The authors assessed the efficacy and safety of a higher dose of budesonide/formoterol in patients with persistent symptomatic asthma.

[Cell and fluid permeability of the alveolar wall in sarcoidosis].

The value of BAL in three groups of diseases (sarcoidosis, lung fibrosis, inflammatory diseases of the bronchi) compared with a control group is described. The cellular components and total protein and glycoprotein as well as electrolyts and angiotension-converting enzyme were examined. In patients with sarcoidosis a higher retention of sodium ions was stated.